|
| Study | Microorganism | Risk factor(s) (RF) | Eye(s) involved | Treatment | Final visual outcome |
|
| Canthrill case n°1 (1980), Ref. [14] | Candida | History of Candida vaginitis | OS | Ppv, intravitreal, and systemic antifungals | 20/200 |
| Canthrill case n°2 (1980), Ref. [14] | Candida | Fever after delivery | OS | Ppv, intravitreal, and systemic antifungals | 20/50 |
| Guex-Crosier (1993), Ref. [18] | Candida | No RF | OD | Oral fluconazole | 20/20 |
| Tsai (2002), Ref. [3] | Candida | History of Candida vaginitis, preterm delivery, acute renal failure, and cardiomegaly | Bilateral | Intravenous antifungal therapy, systemic antibiotic therapy, vitrectomy, and intravitreal antimycotics | OD 6/10 OS counting fingers (CF) |
| Rahman (2011), Ref. [19] | Sphingomonas paucimobilis | No RF premature rupture of membranes | OD | Intravitreal antibiotics, systemic antibiotics, and steroids | 6/9 |
| Wu (2011), Ref. [11] | Candida, Cladosporium | No RF immunocompetent, but suspicion of Candida vaginosis | OS | Ppv and intravitreal antibiotics+antifungals, systemic and topical antifungals, and topical antibiotics | 20/25 |
| Lee (2012), Ref. [13] | Candida | No RF immunocompetent | OD | Ppv, systemic, and intravitreal antifungal therapy | 20/20 |
| Sahu (2013), Ref. [12] | Candida | No RF immunocompetent | OS | Ppv and intravitreal and oral antifungals and oral antibiotics | 20/20 |
| Albloushi (2019), Ref. [15] | Candida | History of diabetes mellitus, vaginal discharge during peripartum period | OD | Ppv and intravitreal antifungals | 20/40 |
| Singh (2020), Ref. [20] | Staphylococcus aureus | No RF immunocompetent, left mastitis | OS | Systemic and intravitreal antibiotics, intravitreal steroids, topical antibiotics, and steroids | 20/400 |
| Bansal (2022), Ref. [16] | Candida | No RF immunocompetent, vaginal infection during pregnancy | OD | Diagnostic core vitrectomy and intravitreal and oral antifungals and steroids | 20/30 |
|
